Adherence to Insulin Pen Therapy Is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus.

Chandran, Arthi; Bonafede, Machaon K; Nigam, Sonali; Saltiel-Berzin, Rita; Hirsch, Laurence J; Lahue, Betsy J

Chandran, Arthi; Bonafede, Machaon K; Nigam, Sonali; Saltiel-Berzin, Rita; Hirsch, Laurence J; Lahue, Betsy J.

Afiliación

Chandran A; Senior Director, Health Economics and Outcomes Research, Becton Dickinson.
Bonafede MK; Director of Outcomes Research, Truven Health Analytics, Cambridge, MA.
Nigam S; Senior Analyst, Health Economics and Outcomes Research, Becton Dickinson, at the time of this study.
Saltiel-Berzin R; World Clinical Education Specialist, Diabetes Care, Department of Medical Affairs, Becton Dickinson.
Hirsch LJ; Worldwide Vice President, Diabetes Care, Department of Medical Affairs, Becton Dickinson.
Lahue BJ; Worldwide Vice President, Health Economics and Outcomes Research, Becton Dickinson, Franklin Lakes, NJ.

Am Health Drug Benefits ; 8(3): 148-58, 2015 May.

Article en En | MEDLINE | ID: mdl-26085903

Palabras clave

diabetes management; healthcare cost; insulin adherence; insulin pen; medical costs; pharmacy costs; type 1 diabetes; type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspecto: Implementation_research Idioma: En Revista: Am Health Drug Benefits Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google